Research

DNDi

Current mission

Switzerland - Since 01/01/2010

Drugs for neglected Diseases initiative (DNDi) is a patient-needs driven, non-for-profit research and development organisation founded in 2003 by seven organisations from around the world:
- The Oswaldo Cruz Foundation from Brazil
- The Indian Council for medical research
- The Kenya Medical Research institute
- The Ministry of Health of Malaysia
- France’s Pasteur institute
- Médecins sans Frontières
- The UNDP/worldBank who’s special program for Research and Training in Tropical Diseases.
DNDi develops safe, effective, and affordable new treatments for diseases such as malaria, sleeping sickness (human African trypanosomiasis), leishmaniasis, and Chagas disease that afflict millions of the world’s poorest people. DNDi’s primary objective is to deliver six to eight new treatments by 2014 and to establish a strong R&D portfolio for these diseases.

  • View the website

Testimonial

The Foundation's support is crucial in order to significantly increase access to treatments

By Dr Bernard Pécoul - General Manager at DNDi

See the testimonial
Research

ICM

Current mission

France - Since 01/01/2010

ICM is a unique medical organisation that carries out research on the prevention and treatment of brain and spinal cord disorders. Innovative in both concept and design, ICM is the sole organization of its kind that brings patients and top medical professionals from around the world under one roof, thereby eliminating the delay between research and its application. Additionally, ICM implements a revolutionary model of multi-disciplinary research that unites the top minds from a variety of medical fields to develop new treatments. ICM is also one of the few private foundations to be recognized as of public usefulness, and thus is able to benefit from the financial support of both public institutions and private funds.

  • View the website

Testimonial

The year 2017 looks already rich in discoveries and in advances on the diseases of the nervous system

By Pr Gérard Saillant - President at ICM

See the testimonial
Research

ARSEP Foundation

Past mission

France - Since 01/01/2011

ARSEP Foundation was created in1969 to finance Multiple Sclerosis (MS) research in France and worldwide. Research is a beacon of hope for patients.
- Multiple Sclerosis affects up to 2 million people in the world.
- ⅔ of the patients are women.
- It’s the principal cause of acquired neurological handicap in adults. It usually starts between the ages of 20 and 40. ARSEP also informs the general public about scientific, medical and therapeutic advances.

  • View the website

Testimonial

Ensure fully and with exigency the totality of the missions to advance, day by day, towards the long awaited treatment.

By Jean Frédéric de LEUSSE - General Manager at ARSEP Foundation

See the testimonial

Our missions for a better future

23 missions since 28, January 2009

  • DNDi

    Switzerland

    Research

    Develops new treatments for diseases that afflicts millions of the world’s poorest people

    Show more
    Show more
  • ICM

    France

    Research

    Carries out research on the prevention and treatment of brain and spinal cord disorders

    Show more
    Show more
  • ARSEP Foundation

    France

    Research

    Finances Multiple Sclerosis research in France and worldwide

    Show more
    Show more